CoreCap Advisors’s Aehr Test Systems AEHR Stock Holding History

CoreCap Advisors’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Buy	1,251 +885	+242%	+$80.9K	﹤0.01%	1033
2026 Q1	$13.6K	Buy	+366	New	+$11.7K	﹤0.01%	1838

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CoreCap Advisors's AEHR Position: Q2 2026 in Review

CoreCap Advisors increased its Aehr Test Systems (AEHR) stake by 242% in Q2 2026, buying an estimated $80.9K and bringing the position to 1,251 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

CoreCap Advisors first reported a position in AEHR in Q1 2026 and has held it in 2 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

CoreCap Advisors held 1,251 shares of Aehr Test Systems worth $120K as of Q2 2026.
CoreCap Advisors bought 885 Aehr Test Systems shares in Q2 2026, an estimated $80.9K.
Aehr Test Systems made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1033 holding.
CoreCap Advisors first reported a position in Aehr Test Systems in Q1 2026 and has held it in 2 quarters since.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.